CST3 and ischemic stroke: The Tromsø Study, for instance, failed to demonstrate an independent association between cystatin C and incident ischemic stroke after multivariable adjustment, although it did identify cystatin C as a mortality risk factor specifically in women (adjusted HR: 1.38 for the highest quartile) [14].